🇺🇸 Ephedrine-S in United States

13 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 13

Most-reported reactions

1. Drug Interaction — 3 reports (23.08%)
2. Cerebrovascular Accident — 2 reports (15.38%)
3. Agitation — 1 report (7.69%)
4. Amnesia — 1 report (7.69%)
5. Blood Pressure Increased — 1 report (7.69%)
6. Condition Aggravated — 1 report (7.69%)
7. Confusional State — 1 report (7.69%)
8. Depression — 1 report (7.69%)
9. Disorientation — 1 report (7.69%)
10. Dizziness — 1 report (7.69%)

Source database →

Frequently asked questions

Is Ephedrine-S approved in United States?

Ephedrine-S does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Ephedrine-S in United States?

Dalian Municipal Central Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.